FULGENT GENETICS, INC. Increase Decrease In Operating Lease Liability
FULGENT GENETICS, INC. (FLGT) reported Increase Decrease In Operating Lease Liability of -$886.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-07-30
- FULGENT GENETICS, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$505.00K.
- FULGENT GENETICS, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$381.00K.
- FULGENT GENETICS, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$446.00K.
- FULGENT GENETICS, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$470.00K.
- FULGENT GENETICS, INC. increase decrease in operating lease liability for fiscal 2025 was -$1.63M.
- FULGENT GENETICS, INC. increase decrease in operating lease liability for fiscal 2024 was -$3.77M.
- FULGENT GENETICS, INC. increase decrease in operating lease liability for fiscal 2023 was -$6.29M.
- FULGENT GENETICS, INC. increase decrease in operating lease liability for fiscal 2022 was -$4.83M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$505.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$886.00K 10-Q · filed 2026-07-30 | -$1.33M derived: sum of 3 quarters · filed 2026-07-30 | -$1.80M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$381.00K 10-Q · filed 2026-05-01 | -$827.00K derived: sum of 2 quarters · filed 2026-05-01 | -$1.30M derived: sum of 3 quarters · filed 2026-05-01 | -$1.65M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$446.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$916.00K derived: sum of 2 quarters · filed 2026-02-27 | -$1.27M derived: sum of 3 quarters · filed 2026-07-30 | -$1.63M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$470.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$825.00K derived: sum of 2 quarters · filed 2026-07-30 | -$1.18M 10-Q · filed 2025-11-07 | -$1.66M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$355.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$709.00K 10-Q · filed 2026-07-30 | -$1.19M derived: sum of 3 quarters · filed 2026-07-30 | -$1.79M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$354.00K 10-Q · filed 2026-05-01 | -$837.00K derived: sum of 2 quarters · filed 2026-05-01 | -$1.44M derived: sum of 3 quarters · filed 2026-05-01 | -$2.61M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | -$483.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$1.08M derived: sum of 2 quarters · filed 2026-02-27 | -$2.26M derived: sum of 3 quarters · filed 2026-02-27 | -$3.77M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$601.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$1.78M derived: sum of 2 quarters · filed 2025-11-07 | -$3.29M 10-Q · filed 2025-11-07 | -$4.81M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$2.69M 10-Q · filed 2025-08-01 | -$4.21M derived: sum of 3 quarters · filed 2026-02-27 | -$5.83M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$1.51M 10-Q · filed 2025-05-02 | -$3.04M derived: sum of 2 quarters · filed 2026-02-27 | -$4.66M derived: sum of 3 quarters · filed 2026-02-27 | |
| 2023-12-31 | -$1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$3.14M derived: sum of 2 quarters · filed 2026-02-27 | -$6.29M 10-K · filed 2026-02-27 | |
| 2023-09-30 | -$1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$4.76M 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | -$3.14M 10-Q · filed 2024-08-02 | |||
| 2022-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$3.15M derived: sum of 2 quarters · filed 2025-02-28 | -$4.83M 10-K · filed 2025-02-28 | |
| 2022-09-30 | -$1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$3.33M 10-Q · filed 2023-11-03 | ||
| 2022-06-30 | -$1.68M 10-Q · filed 2023-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |